MANAGEMENT OF PRIMARY INFERTILITY DUE TO PID WITH AYURVEDA: A CASE STUDY
Keywords:
infertility, yonivyapada, ayurved, PID, bandhyatvaAbstract
Introduction -Female infertility is a serious issue in Indian society. Female contributes about 40% cases of infertile couples. From all the various factors, one of the contributing factors is PID. Infection and inflammation of the upper genital tract, termed as pelvic inflammatory disease (PID), may be complicated by infertility and ectopic pregnancy. In Ayurveda symp-toms of PID can be correlated with Paripluta Yonivyapada. Ayurvedic treatment can bypass the surgical management to avoid the related burden and provide a fruitful outcome in such conditions. Here, we present a case of primary infertility with a known Pelvic inflammatory disease came to OPD of Prasuti tantra evum striroga dept., M.M.M. Govt. Ayurved College, Udaipur Rajasthan. Aim- To evaluate the therapeutic effect of certain Ayurvedic indigenous drugs in Primary in-fertility caused as a complication of Pelvic Inflammatory Disease. Materials and methods- The patient was treated with the basic principles of treatment of Paripluta yonivyapada. She was given vata & pitta dosha pacifying treatment with drugs like Pachtiktaghrita guggulu, Triphalaguggulu, Amlaki rasayana and tridosha balancing Phalaghrita along with yoni prakshalan with Panchwalkala kwath and vaginal tampon with Jatyadi tail. Result - The patient got satisfactory result with Ayurveda treatment without use of antimicro-bial therapy and she conceived after two months of treatment confirmed by TVS USG and delivered healthy male child weighing 2.9kg by normal vaginal delivery on 22nd august 2023. Conclusion – Infertility due to PID can be efficiently managed by following extensive Ay-urvedic treatment by integrating both internal and local Ayurvedic medications.
Downloads
Published
How to Cite
Issue
Section
Copyright (c) 2023 Monika Kumari, Narendra Kumar Meena, Mahesh Dixit

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.